These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8912139)

  • 1. Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
    Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
    J Gastroenterol Hepatol; 1996 Oct; 11(10):985-92. PubMed ID: 8912139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.
    Hori N; Okanoue T; Sawa Y; Itoh Y; Mori T; Takami S; Kashima K
    J Gastroenterol; 1994 Aug; 29(4):460-8. PubMed ID: 7951857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
    García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
    J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment of portal hypertension with ritanserin and propranolol in conscious and unrestrained cirrhotic rats.
    Pomier-Layrargues G; Giroux L; Rocheleau B; Huet PM
    Hepatology; 1992 May; 15(5):878-82. PubMed ID: 1568730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic effects of molsidomine and propranolol in patients with cirrhosis.
    Combis JM; Vinel JP; Badia P; Barange K; Payen JL; Combis F; Desmorat H; Pascal JP
    Br J Clin Pharmacol; 1996 May; 41(5):409-13. PubMed ID: 8735682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.
    Ruiz del Arbol L; García-Pagán JC; Feu F; Pizcueta MP; Bosch J; Rodés J
    J Hepatol; 1991 Sep; 13(2):179-86. PubMed ID: 1744422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model.
    Kroeger RJ; Groszmann RJ
    Hepatology; 1985; 5(3):425-30. PubMed ID: 3922868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
    Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T
    Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride-induced cirrhosis.
    Desmorat H; Vinel JP; Lahlou O; Pipy B; Badia P; Cales P; Combis JM; Souqual MC; Pascal JP
    Hepatology; 1991 Jun; 13(6):1181-4. PubMed ID: 2050332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a somatostatin analogue (SMS 201-995) on hemodynamics and glucagon secretion in cirrhotic rats.
    Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
    Gastroenterol Jpn; 1993 Apr; 28(2):276-83. PubMed ID: 8486215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
    Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
    J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
    Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
    Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
    Reboredo M; Chang HC; Barbero R; Rodríguez-Ortigosa CM; Pérez-Vizcaíno F; Morán A; García M; Banales JM; Carreño N; Alegre F; Herrero I; Quiroga J; Prieto J; Sangro B
    PLoS One; 2013; 8(1):e52683. PubMed ID: 23341903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
    Morillas RM; Planas R; Cabré E; Galán A; Quer JC; Feu F; García Pagán JC; Bosch J; Gassull MA
    Hepatology; 1994 Dec; 20(6):1502-8. PubMed ID: 7982651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.
    D'Amico M; Mejías M; García-Pras E; Abraldes JG; García-Pagán JC; Fernández M; Bosch J
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1191-8. PubMed ID: 22403792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats.
    Van de Casteele M; Hösli M; Sägesser H; Reichen J
    J Hepatol; 1999 Aug; 31(2):300-5. PubMed ID: 10453944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
    Moreau R; Cailmail S; Valla D; Lebrec D
    Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.
    Koshy A; Girod C; Lee SS; Hadengue A; Cerini R; Lebrec D
    Hepatology; 1989 Feb; 9(2):269-73. PubMed ID: 2912829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nipradilol, a new beta-blocker with vasodilatory properties, in experimental portal hypertension: a comparative haemodynamic study with propranolol.
    Um S; Nishida O; Tokubayashi M; Kimura F; Kita T
    J Gastroenterol Hepatol; 1993; 8(5):414-9. PubMed ID: 8105997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic evaluation of molsidomine: a vasodilator with antianginal properties in patients with alcoholic cirrhosis.
    Vinel JP; Monnin JL; Combis JM; Calés P; Desmorat H; Pascal JP
    Hepatology; 1990 Feb; 11(2):239-42. PubMed ID: 2307402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.